Zhejiang Medicine Co., Ltd. (SHA:600216)

China flag China · Delayed Price · Currency is CNY
13.38
-0.28 (-2.05%)
Apr 28, 2025, 2:45 PM CST
40.40%
Market Cap 13.14B
Revenue (ttm) 9.38B
Net Income (ttm) 1.46B
Shares Out 961.64M
EPS (ttm) 1.54
PE Ratio 8.87
Forward PE 10.16
Dividend 0.15 (1.10%)
Ex-Dividend Date Jul 10, 2024
Volume 22,549,954
Average Volume 21,971,138
Open 13.63
Previous Close 13.66
Day's Range 13.34 - 13.63
52-Week Range 9.36 - 19.40
Beta 0.57
RSI 48.38
Earnings Date Apr 24, 2025

About Zhejiang Medicine

Zhejiang Medicine Co., Ltd. manufactures and sells life nutrition and pharmaceutical products in China. The company products include synthetic vitamin E, natural vitamin E, β-carotene, cantharidin, vancomycin hydrochloride, and teicoplanin. It also offers fat-soluble vitamins, retinoids, quinolone antibiotics, anti-resistance antibiotics, and other products, as well as animal nutrition products. In addition, the company provides injectable levofloxacin lactate, injectable vancomycin hydrochloride injections, and injectable teicoplanin products.... [Read more]

Sector Healthcare
Founded 1997
Employees 6,227
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 600216
Full Company Profile

Financial Performance

In 2024, Zhejiang Medicine's revenue was 9.38 billion, an increase of 20.29% compared to the previous year's 7.79 billion. Earnings were 1.16 billion, an increase of 170.11%.

Financial Statements

News

There is no news available yet.